AngioDynamics Inc (AngioDynamics) is a medical technology company that designs, manufactures and markets minimally invasive and image-guided therapeutics and diagnostic devices for the treatment of peripheral vascular disease (PVD), tumors and other non-coronary diseases. The company distributes its products using a direct sales force in the US and a heavy reliance on third-party distributors internationally.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

AngioDynamics drives its growth by continuously developing innovative medical technologies and enhancing existing products through a blend of internal research and development, technology licensing, strategic alliances, and acquisitions. The company's dedicated R&D engineering teams operate out of leased research facilities located in Marlborough, Massachusetts (17,200 sq. ft.) and Rehovot, Israel (4,300 sq. ft.). The R&D division works in close partnership with internal marketing, sales, regulatory, and compliance teams to directly integrate critical customer and physician feedback into the product design pipeline. This collaborative, physician-driven framework has established AngioDynamics as a preferred development partner among interventional clinicians. In FY2026, the company spent US$29.4 million on its R&D activities, which as a percentage of revenue stood at 9.2%, and grew 12.3% YoY.